There was an overall significant difference of the % glucose and xylose released from untreated biomass during enzymatic saccharification between the WT and the three engineered lines, F 3,12) = 30.59, P < 0.0001, F 3,12) = 66.83, P < 0.0001, xylose for the 70 °C pretreated biomass, F 3,12) = 139.36, P < 0.0001, and glucose for the 140 °C pretreated biomass, F 3,12) = 18.57, P < 0.001.
There was a strongly significant difference of the B-glucose between the two subgroups (p < 0.0001).
However, despite these more pronounced effects on FPG and beta-cell function, we did not find a significant difference of postprandial or overall interstitial glucose load and HbA1c with insulin glargine compared to metformin at study end (Fig. 1).
There was no significant difference of initial rate of xylose release between the groups in untreated (xylose, F 3,12) = 0.62, P = 0.62), but there was a significant difference between groups for initial rate of glucose release (glucose, F 3,12) = 11.22, P < 0.05).
Mean comparison of glucose, BHBA and urea concentrations among flocks showed significant differences for glucose (F = 37.4, P < 0.001), BHBA (F = 15.5, P < 0.001) and urea (F = 3.2, P < 0.01) concentrations among flocks.
Although fewer patients were recruited than originally planned, a clear and significant difference between glucose levels of 1.41 mmol/L (25 mg/dL) was achieved (with 97.7% power), which has been associated with a 22% decrease in mortality in previously published epidemiologic analysis (6).
There are some significant differences, of course.
There were significant differences, of course.
No significant difference in glucose consumption was observed between any of the cultures containing syringic, homovanillic, 4-hydroxybenzoic, gallic acid or vanillylidenacetone, and the control (Figure 3).
